Sinopharm
1099.HK
#2002
Rank
C$11.23 B
Marketcap
$3.60
Share price
-2.43%
Change (1 day)
2.70%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : C$52.03 Billion

According to Sinopharm's latest financial reports the company's total liabilities are C$52.03 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sinopharm - Total liabilities on balance sheet (from 2008 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$50.04 B6.12%
2021-12-31C$47.15 B8.99%
2020-12-31C$43.26 B19.92%
2019-12-31C$36.07 B8.73%
2018-12-31C$33.17 B29.32%
2017-12-31C$25.65 B17.12%
2016-12-31C$21.90 B3.84%
2015-12-31C$21.09 B21.85%
2014-12-31C$17.31 B28.07%
2013-12-31C$13.51 B45.67%
2012-12-31C$9.27 B21.36%
2011-12-31C$7.64 B85.29%
2010-12-31C$4.12 B43.83%
2009-12-31C$2.86 B26.46%
2008-12-31C$2.26 B42.15%
2007-12-31C$1.59 B18.89%
2006-12-31C$1.34 B